India’s ministry of health and family welfare has banned the popular diabetes drug pioglitazone, the painkiller metamizole, and the psychiatric combination flupentixol with melitracen with immediate effect, because it said that their use was “likely to involve risk to human beings.” The move is a response to a report from a parliamentary standing committee in April that criticised the ministry for failing to withdraw several drugs …
No takes yet. Share an insight, caveat, or question.
Soumyadeep Bhaumik (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: